These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 32163529)
21. Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study. Merante D; Rosenstock J; Sharma U; Feins K; Hsu C; Vinik A; Pain Med; 2017 Nov; 18(11):2198-2207. PubMed ID: 28371941 [TBL] [Abstract][Full Text] [Related]
22. Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double-blind, placebo-controlled phase III study in Asian patients. Baba M; Matsui N; Kuroha M; Wasaki Y; Ohwada S J Diabetes Investig; 2019 Sep; 10(5):1299-1306. PubMed ID: 30672128 [TBL] [Abstract][Full Text] [Related]
23. Safety of mirogabalin and pregabalin in Japanese patients with neuropathic pain: a retrospective cohort study. Nakajima R; Ooba N; Kamei M; Hashiba H; Miyazaki C Expert Opin Drug Saf; 2023; 22(9):841-848. PubMed ID: 36945742 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of add-on mirogabalin to conventional therapy for the treatment of peripheral neuropathic pain after thoracic surgery: the multicenter, randomized, open-label ADMIT-NeP study. Miyazaki T; Matsumoto K; Sato T; Sano I; Furukawa K; Shimoyama K; Kamohara R; Suzuki M; Kondou M; Ikeda N; Tabata S; Shiosakai K; Nagayasu T; BMC Cancer; 2024 Jan; 24(1):80. PubMed ID: 38225552 [TBL] [Abstract][Full Text] [Related]
25. Mirogabalin and emerging therapies for diabetic neuropathy. Javed S; Alam U; Malik RA J Pain Res; 2018; 11():1559-1566. PubMed ID: 30174455 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study. Vinik A; Rosenstock J; Sharma U; Feins K; Hsu C; Merante D; Diabetes Care; 2014 Dec; 37(12):3253-61. PubMed ID: 25231896 [TBL] [Abstract][Full Text] [Related]
27. Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients. Kato J; Matsui N; Kakehi Y; Murayama E; Ohwada S; Sugihara M Pain; 2019 May; 160(5):1175-1185. PubMed ID: 30913164 [TBL] [Abstract][Full Text] [Related]
28. Occurrence of somnolence and respiratory depression induced by pregabalin and mirogabalin use and the influence of opioid treatment using the Japanese adverse drug event report database. Kato H; Koseki T; Kondo M Pharmazie; 2024 Aug; 79(7):169-172. PubMed ID: 39152553 [No Abstract] [Full Text] [Related]
29. Efficacy and safety of mirogabalin treatment in patients with diabetic peripheral neuropathic pain: A systematic review and meta-analysis of randomised controlled trials. Alyoubi RA; Alshareef AA; Aldughaither SM; Aljaroudi AM; Alabdulwahed A; Alduraibi FM; Masoud AT; Abu-Zaid A Int J Clin Pract; 2021 May; 75(5):e13744. PubMed ID: 32991782 [TBL] [Abstract][Full Text] [Related]
30. Clinical Effectiveness of Mirogabalin Besylate for Trigeminal Neuropathy after Skull Base Surgery: Illustrative Cases. Karatsu K; Tamura R; Miyauchi T; Sogano J; Hino U; Iwama T; Toda M Medicines (Basel); 2023 Aug; 10(8):. PubMed ID: 37623812 [TBL] [Abstract][Full Text] [Related]
31. Analgesic characteristics of a newly developed α Komatsu S; Nakamura S; Nonaka T; Yamada T; Yamamoto T Mol Pain; 2021; 17():17448069211052167. PubMed ID: 34823399 [TBL] [Abstract][Full Text] [Related]
32. [Analgesic Effects of Mirogabalin for Cancer Pain]. Nakanishi K; Ota C; Yomiya K Gan To Kagaku Ryoho; 2020 Jun; 47(6):927-931. PubMed ID: 32541170 [TBL] [Abstract][Full Text] [Related]
33. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis. van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034 [TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of mirogabalin for the treatment of post-herpetic neuralgia in Taiwan. Ye X; Gray E; Wang YF; Wang SJ J Med Econ; 2020 May; 23(5):529-536. PubMed ID: 31971469 [No Abstract] [Full Text] [Related]
35. Tolerability, pharmacokinetics, and pharmacodynamics of mirogabalin in healthy subjects: Results from phase 1 studies. Brown K; Mendell J; Ohwada S; Hsu C; He L; Warren V; Dishy V; Zahir H Pharmacol Res Perspect; 2018 Oct; 6(5):e00418. PubMed ID: 30151212 [TBL] [Abstract][Full Text] [Related]
36. Determinants of interactions of a novel next-generation gabapentinoid NVA1309 and mirogabalin with the Cavα2δ-1 subunit. Souza IA; Gandini MA; Ali MY; Kricek F; Skouteris G; Zamponi GW Mol Brain; 2024 Aug; 17(1):54. PubMed ID: 39113108 [TBL] [Abstract][Full Text] [Related]
37. Long-term safety and efficacy of mirogabalin in Asian patients with postherpetic neuralgia: Results from an open-label extension of a multicenter randomized, double-blind, placebo-controlled trial. Kato J; Matsui N; Kakehi Y; Murayama E; Ohwada S Medicine (Baltimore); 2020 Sep; 99(36):e21976. PubMed ID: 32899037 [TBL] [Abstract][Full Text] [Related]
38. Switching From Pregabalin to Mirogabalin in Patients with Peripheral Neuropathic Pain: A Multi-Center, Prospective, Single-Arm, Open-Label Study (MIROP Study). Kimura Y; Yamaguchi S; Suzuki T; Kato J; Chiba S; Hirakawa N; Yamaguchi K; Tanabe Y; Takatsuna H; Kenyoshi Y; Shiosakai K; Sakai M; Iseki M Pain Ther; 2021 Jun; 10(1):711-727. PubMed ID: 33856660 [TBL] [Abstract][Full Text] [Related]
39. Anxiolytic-like effects of mirogabalin, a novel ligand for α Murasawa H; Kobayashi H; Yasuda SI; Saeki K; Domon Y; Arakawa N; Kubota K; Kitano Y Pharmacol Rep; 2020 Jun; 72(3):571-579. PubMed ID: 32270470 [TBL] [Abstract][Full Text] [Related]
40. Mirogabalin as a Therapeutic Option for Neuropathic Pain Emerging Post-endodontic Treatment: A Two-Case Report. Shimizu K; Yasukawa T; Ohara K; Noma N; Hayashi M; Takeichi O J Endod; 2024 Sep; 50(9):1351-1356. PubMed ID: 38901645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]